Preoperative blood management and the role of erythropoietin in orthopedic surgery;Strategie preoperatoire d'epargne sanguine homologue et erythropoietine en peri-chirurgie

Transfusion Clinique et Biologique

Volumn 6, Issue 6, 1999, Pages 370-379

  Rosencher, N ^a   Woimant, G ^b   Ozier, Y ^a   Conseiller, C ^a  

^a HÔpital Cochin   (France)

^b université Paris Cité   (France)

Author keywords

Calculated blood loss; Erythropoietin; Iron substitution; Transfusion algorithm

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; IRON;

ALGORITHM; BLEEDING; BLOOD TRANSFUSION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; ERYTHROCYTE; HEMATOCRIT; ORTHOPEDIC SURGERY; PREOPERATIVE CARE; ANEMIA; BLOOD AUTOTRANSFUSION; COMORBIDITY; ECONOMICS; EVALUATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MULTICENTER STUDY; ORTHOPEDICS; PEROPERATIVE CARE; PREMEDICATION; REVIEW;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; COMORBIDITY; COST-BENEFIT ANALYSIS; EPOETIN ALFA; EVALUATION STUDIES; HEMATOCRIT; HUMANS; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE CARE; IRON; MULTICENTER STUDIES; ORTHOPEDICS; PREMEDICATION; PREOPERATIVE CARE;

EID: 0033256735     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(00)88982-X     Document Type: Conference Paper

References (11)

1. Conférence de Consensus. Utilisation des globules rouges pour la compensation des pertes sanguines en chirurgie de l'adulte. Ann Fr Anaesth Reanim 1995; 14: 1-117.
2. Forgie M, Wells P, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: Results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998; 158: 610-6.
3. Canadian, Orthopedic, Perioperative, Erythropoietin, Groups. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 341: 1227-32.
4. Faris P. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med 1996; 101 Suppl: 28-32.
5. Goldberg M. Perioperative epoietin alfa increases red blood cell mass and reduces exposure to transfusions: Results of randomised clinical trials. Semin Hematol 1997; 34: 41-7.
6. De Andrade J, Jove M, Landon G, Frei D, Guilfoyle M, et al. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996; 25: 533-42.
7. De Andrade J, Frei D, Guilfoyle M. Integrated analysis of thrombotic/vascular event occurence in epoietin alfa. treated patients undergoing major, elective orthopedic surgery. Orthopedics 1999; 22: 111-8.
8. Biesma D, Kraaijenhagen R, Poortman J, Marx J, van de Wiel A. The effect of oral iron supplementation on erythropoiesis in autologous blood donnors. Transfusion 1992; 32: 162-5.
9. Goodnough L, Monk T, Andriole G. Erythropoietin therapy. N Engl J Med 1997; 336: 933-8.
10. Rutherford C, Sneider T, Dempsey H, Kim D, Brugnara C, Goldberg M. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulating perisurgical setting: The importance of iron availability in optimizing response. Transfusion 1996; 36: 822-6.
11. Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33: 55-60.